Hint mode is switched on Switch off

Picard Medical, ordinary share
PMI, US71953R1086

Add a stock to WL
Choose all Reset all
Picard Medical, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) ...
Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Picard Medical, Inc.
  • Industry
    Medical Devices

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    AMEX
  • Ticker
    PMI
  • Placement
    06.05.2026
  • Lock up period
    180
  • Number of papers
    16,666,667
  • Volume of raised funds
    5 mln USD
  • Placement share
    18.11%
  • Final placement price
    0.3 USD
  • Price change since placement date
    -12.05%
  • By capitalization
    27.61 mln USD

IFRS/US GAAP reports

2025
II q eng
IV q eng

Indicators

News

01/06/2026 Picard Medical: Departure Of Directors Or Certain Officers
15/05/2026 Picard Medical: Results Of Operations And Financial Condition, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Regulation Fd Disclosure, Financial Statements And Exhibits
05/05/2026 Picard Medical: Entry Into A Material Definitive Agreement, Unregistered Sale Of Equity Securities, Financial Statements And Exhibits
05/05/2026 Picard Medical: Entry Into A Material Definitive Agreement, Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Financial Statements And Exhibits
07/04/2026 Picard Medical: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Unregistered Sale Of Equity Securities, Material Modification To Rights Of Security Holders, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.